Oncology News

Oncology

sponsor
Become a Member Today!
Register
Email:


Password:

Remember me
Forgot your Password?
Invite Code?
Article ID

Your Article Summary

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Voso MT et al. – The data show that the 5–AZA/VPA combination is active and safe in patients with MDS with a poor prognosis. Achievement of VPA therapeutic levels may indeed increase 5–AZA efficacy.

Today in Basic Science/Genetics...keeping you current

Multi-step binding of ADAMTS-13 to von Willebrand factor
Journal of Thrombosis and Haemostasis, 12/02/09

Combined genetic effect of CDK7 and ESR1 polymorphisms on breast cancer
Breast Cancer Research and Treatment, 12/02/09

UHRF1 is associated with epigenetic silencing of BRCA1 in sporadic breast cancer
Breast Cancer Research and Treatment, 12/02/09


Sponsor

Article Search

Keyword:

Search:

Published within

Sort By:
Date
Relevance


Sponsor

Sponsor

Send this Summary to a Colleague

Enter email address